Primary Cells

Human Chronic Myeloid Leukemia PB Plasma (Chronic Phase)

  • For research use only

Cat No.

ABC-TC3364

Product Type

Blood Products

Cell Type

Plasma

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Chronic Myeloid Leukemia

Storage

Liquid Nitrogen

Explore Human Chronic Myeloid Leukemia PB Plasma (Chronic Phase) for hematology, enabling biomarker discovery, therapy monitoring, and cancer biology.

Product Image

Description

Human Chronic Myeloid Leukemia (CML) Peripheral Blood (PB) Plasma (Chronic Phase) is isolated from peripheral blood samples collected from human donors diagnosed with CML in the chronic phase. The sample type is acellular plasma, obtained by centrifugation of whole blood. This plasma contains soluble biological molecules including cytokines, chemokines, extracellular vesicles, and metabolites released by circulating leukemic and immune cells. In the chronic phase of CML, the plasma composition reflects relatively stable disease activity, typically featuring early immune dysregulation and BCR-ABL fusion product signatures. Each lot undergoes rigorous screening and isolation procedures and is tested to ensure it is free from contamination by HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
Product Code

Human Chronic Myeloid Leukemia PB Plasma (Chronic Phase), Human CML PB Plasma, Peripheral Blood Plasma, Plasma, CML PB Plasma (CP)

Species

Human

Cat.No

ABC-TC3364

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Plasma

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Chronic Myeloid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Blood Products

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Chronic Myeloid Leukemia (CML) Peripheral Blood (PB) Plasma (Chronic Phase) is well-suited for early stage leukemia research, including biomarker validation, cytokine profiling, proteomics, and development of diagnostic assays. It is also ideal for studies assessing systemic immune function and molecular signatures of chronic-phase myeloproliferative disease. Moreover, it serves as a valuable resource for the preliminary screening of potential therapeutic agents in the early stages of drug development for CML.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Chronic Myeloid Leukemia PB Plasma (Chronic Phase)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button